https://www.dailyhealthindustry.it/bayer-per-la-divisione-farmaceutica-un-2026-resiliente/ 2026-03-06T10:40:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazioni-cliniche-dallema-nuove-linee-guida-per-le-emergenze-di-salute-pubblica-in-ue/ 2026-03-06T13:42:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-della-prostata-documento-fondazione-aiom-la-qualita-di-vita-deve-diventare-un-endpoint-primario/ 2026-03-06T14:53:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dai-silos-al-team-la-cura-cambia-quando-cambia-lorganizzazione/ 2026-03-07T11:17:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/excellence-show-5-sostenibilita-competitiva-quando-lesg-smette-di-essere-marketing/ 2026-03-07T11:07:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/excellence-show-6-verba-volant-acta-manent-linnovazione-aperta-che-arriva-fino-al-paziente/ 2026-03-07T11:20:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-un-dossier-per-capire-come-lia-sta-rivoluzionando-il-mondo-del-pharma/ 2026-03-08T15:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colangite-biliare-primitiva-gsk-cede-i-diritti-di-linerixibat-ad-alfasigma/ 2026-03-09T08:56:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/compugroup-medical-acquisisce-new-line-ricerche-di-mercato-e-rafforza-le-soluzioni-data-driven-per-la-sanita/ 2026-03-09T11:10:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-arianna-gregis-e-la-nuova-ad/ 2026-03-09T16:13:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-aifa-approva-approva-ribociclib-per-ridurre-il-rischio-di-recidiva-nel-tumore-al-seno-in-fase-iniziale/ 2026-03-09T14:18:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-menarini-alza-lasticella-4887-mld-di-fatturato-nel-2025-62/ 2026-03-09T14:51:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-investe-nelloncologia-pediatrica-acquisita-la-statunitense-day-one-biopharmaceuticals-per-25-miliardi-di-dollari/ 2026-03-09T16:07:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-dopo-un-mandato-controverso-vinay-prasad-lascia-lagenzia/ 2026-03-09T15:47:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-obinutuzumab-efficace-nel-controllo-del-les-i-dati-dello-studio-allegory-su-nejm/ 2026-03-10T09:58:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-linee-guida-piu-snelle-per-i-biosimilari-meno-test-pk-piu-approvazioni-rapide/ 2026-03-10T10:53:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-cede-bu-capsule-e-ingredienti-per-la-salute-a-lone-star-per-3-miliardi-di-dollari/ 2026-03-10T11:37:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-da-aifa-ok-a-rimborsabilita-di-seladelpar-nella-colangite-biliare-primitiva/ 2026-03-10T13:53:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/egualia-riccardo-zagaria-doc-pharma-nuovo-presidente/ 2026-03-10T14:41:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-svolta-storica-i-fondatori-lasciano-per-una-nuova-startup-mrna/ 2026-03-11T13:21:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-una-bu-autonoma-per-i-biosimilari/ 2026-03-11T14:07:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-ok-ce-per-zynyz-prima-immunoterapia-sistemica-per-il-carcinoma-a-cellule-squamose-del-canale-anale/ 2026-03-11T14:47:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-15-miliardi-di-dollari-per-espandere-lo-stabilimento-di-plasmaderivati-in-illinois/ 2026-03-11T15:31:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-3-miliardi-di-dollari-in-cina-per-rafforzare-la-produzione-di-orforglipron/ 2026-03-12T09:40:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/india-a-febbraio-il-mercato-farmaceutico-cresce-dell11/ 2026-03-12T10:49:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-evaluate-pharma-2026-malattie-rare-un-mercato-da-400-miliardi-di-dollari-entro-il-2032/ 2026-03-12T14:15:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/santhera-pharmaceuticals-vamorolone-conferma-benefici-a-lungo-termine-nella-dmd/ 2026-03-12T15:28:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-progressi-nella-lotta-allhiv-1-con-dor-isl-primo-regime-non-insti-a-due-farmaci/ 2026-03-13T14:20:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-collaborazione-con-bespak-per-la-produzione-di-inalatori-a-basse-emissioni-nel-regno-unito/ 2026-03-13T13:44:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alert-lilly-copie-di-zepbound-potrebbero-essere-pericolose-lazienda-chiede-lintervento-della-fda/ 2026-03-13T14:18:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-un-top-manager-per-guidare-ladozione-dellai/ 2026-03-13T15:23:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-al-via-servizio-di-video-interpretariato-in-lis-per-i-dipendenti-aifa-al-via-servizio-di-video-interpretariato-in-lis-per-i-dipendenti-con-disabilita-uditiva/ 2026-03-16T10:30:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-tumore-al-seno-il-sud-fa-rete-con-il-modello-beacon/ 2026-03-16T11:09:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/exeltis-allarga-il-proprio-business-alla-neurologia/ 2026-03-16T13:32:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-loms-indica-tre-priorita-globali-per-orientare-la-ricerca/ 2026-03-16T14:03:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-le-serie-a-women-in-campo-con-ladesivo-messaggio-blocca-lhpv-con-la-vaccinazione/ 2026-03-17T10:23:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-raddoppia-in-asia-per-orforglipron-dopo-la-cina-produzione-e-supply-chain-rafforzate-in-giappone/ 2026-03-17T11:18:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dubai-hub-delle-life-sciences-tra-investimenti-e-tensioni-geopolitiche/ 2026-03-17T15:16:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-efpia-lue-e-uneccellenza-scientifica-tradurre-questa-capacita-in-investimenti-farmaceutici-porterebbe-120-miliardi-in-10-anni/ 2026-03-17T15:09:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-aifa-approva-la-rimborsabilita-di-garadacimab-nellangioedema-ereditario/ 2026-03-18T10:20:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-sceglie-sara-villa-come-patient-advocacy-manager/ 2026-03-18T11:13:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-sulla-pipeline-biosimilari-collaborazione-con-samsung-bioepis/ 2026-03-18T14:18:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-dal-programma-prime-nuovi-strumenti-per-lo-sviluppo-dei-farmaci-destinati-agli-unmet-needs/ 2026-03-18T16:04:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-chiarisce-sulla-rimborsabilita-di-lecanemab-e-donanemab-per-lalzheimer/ 2026-03-19T10:33:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/modelli-regolatori-quanto-si-assomigliano-ema-e-fda/ 2026-03-19T16:55:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-ok-fda-a-linerixibat-nella-colangite-biliare-primitiva/ 2026-03-19T13:23:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-diabete-risultati-positivi-per-triplo-agonista-retatrutide-dallo-studio-transcend-t2d-1/ 2026-03-19T14:31:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-nuova-sede-a-milano/ 2026-03-19T15:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-accelera-lo-stop-alla-sperimentazione-animale-e-lancia-una-bozza-di-linee-guida-sulle-nams/ 2026-03-19T16:19:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ipertensione-resistente-ai-farmaci-parere-europeo-positivo-per-la-quadripillola/ 2026-03-23T11:12:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-terapie-car-t-in-cina-con-un-nuovo-stabilimento-a-shanghai/ 2026-03-23T11:53:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-istat-2026-export-boom-per-il-pharma-verso-gli-usa-ma-cresce-la-dipendenza-dalla-cina/ 2026-03-23T13:26:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiom-e-quotidiano-sanita-insieme-per-qs-oncologia-ecco-la-nuova-piattaforma-di-confronto/ 2026-03-23T13:54:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-tumore-della-prostata-mhspc-via-libera-ue-alla-combinazione-a-base-di-niraparib-piu-aap-nei-pazienti-con-mutazioni-brca/ 2026-03-23T14:13:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-3-miliardi-di-dollari-a-synnovation-therapeutics-per-candidato-polivalente/ 2026-03-23T14:50:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-via-libera-fda-a-wegovy-hd-la-dose-piu-alta-di-semaglutide/ 2026-03-23T15:35:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-allo-spallanzani-la-formazione-tobia-sanita-piu-inclusiva-per-la-disabilita-complessa/ 2026-03-24T09:57:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-fiaso-alleanza-strategica-per-la-sicurezza-dei-pazienti-lappropriatezza-delle-cure-e-la-sostenibilita-del-ssn/ 2026-03-24T10:07:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-linfoma-di-hodgkin-nuove-indicazioni-per-nivolumab-ok-da-fda-e-commissione-europea/ 2026-03-24T10:53:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-investe-nelle-malattie-autoimmuni-acquisita-ouro-medicines-per-22-miliardi-di-dollari/ 2026-03-24T11:42:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-malattie-rare-laifa-approva-rimborsabilita-di-omaveloxolone-nellatassia-di-friedreich/ 2026-03-24T13:51:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-negoziazione-dei-farmaci-via-alle-nuove-procedure-semplificate-e-fast-track/ 2026-03-24T14:06:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amcham-e-luiss-libro-bianco-sulle-imprese-farmaceutiche-statunitensi-in-italia-una-produzione-che-vale-oltre-9-miliardi-di-euro/ 2026-03-24T15:12:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-off-patent-egualia-senza-interventi-mirati-rischio-carenze-e-uscita-dal-mercato-di-molti-medicinali-essenziali/ 2026-03-24T15:49:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-oltre-1-miliardo-di-dollari-per-candidato-anticorpo-tri-specifico-contro-malattie-autoimmuni/ 2026-03-25T09:46:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-marstacimab-prima-profilassi-sottocutanea-per-emofilia-a-e-b-rimborsabile-in-italia/ 2026-03-25T10:43:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-da-22-miliardi-con-quotient-therpaeutics-per-nuovi-target-ibd/ 2026-03-25T11:48:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardio-hub-daiichi-sankyo-italia-punta-su-ascolto-e-co-progettazione-per-le-patologie-cardiovascolari/ 2026-03-25T14:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scienze-della-vita-leuropa-prova-a-riscrivere-le-regole-per-non-perdere-la-sfida-globale/ 2026-03-25T16:50:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aderenza-terapeutica-le-iniziative-del-gruppo-servier-in-italia-per-la-giornata-mondiale/ 2026-03-26T14:11:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/via-libera-dal-cda-alla-rimborsabilita-di-un-nuovo-farmaco-di-7-estensioni-di-indicazioni-terapeutiche-e-di-3-equivalenti/ 2026-03-26T16:22:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-della-distribuzione-dei-farmaci-due-anni-di-rivoluzione-gentile-per-la-prossimita/ 2026-03-26T15:29:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-2025-svelati-i-top-of-the-year/ 2026-03-26T16:38:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-strategia-post-keytruda-acquisita-terns-pharmaceuticals-per-67-miliardi-di-dollari/ 2026-03-26T16:54:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-tempus-ai-insieme-per-accelerare-gli-adc-in-oncologia/ 2026-03-27T10:15:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-nuovo-stabilimento-di-farmaci-biologici-in-georgia/ 2026-03-27T11:13:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-nel-mirino-di-cvc-sul-tavolo-offerta-da-109-miliardi-di-euro/ 2026-03-27T14:52:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-focus-sullallergologia-acquisita-la-biotech-excellergy-per-2-miliardi-di-dollari/ 2026-03-27T15:42:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-acquisisce-transcend-therapeutics-per-700-milioni-di-dollari/ 2026-03-30T13:28:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-accordo-da-275-miliardi-di-dollari-con-insilico-per-le-terapie-ai-driven/ 2026-03-30T09:45:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-parere-positivo-del-chmp-per-isatuximab-sottocute-nel-mieloma-multiplo-anche-con-iniettore-indossabile/ 2026-03-30T10:52:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharmamar-ok-chmp-a-lurbinectedina-in-combinazione-con-atezolizumab-nel-tumore-polmonare-a-piccole-cellule/ 2026-03-30T13:04:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/opella-gonzalo-balcazar-nuovo-presidente-europa-e-america-latina/ 2026-03-31T08:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-crescita-nel-2025-tra-pipeline-mercati-internazionali-e-nuove-partnership/ 2026-03-31T10:00:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-aifa-rimborsabilita-per-iptacopan-nella-glomerulopatia-da-c3/ 2026-03-31T10:45:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-flu-coalition-una-nuova-alleanza-per-aumentare-la-prevenzione-dellinfluenza-in-italia/ 2026-03-31T13:47:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-acquisisce-apellis-per-56-miliardi-e-punta-su-nefrologia-e-oftalmologia/ 2026-03-31T14:32:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-propone-di-sostituire-i-gruppi-di-controllo-animali-con-comparatori-virtuali-lobiettivo-e-ridurre-la-sperimentazione-animale/ 2026-04-01T09:21:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-continua-lo-shopping-acquisita-la-biotech-centessa-per-63-miliardi-di-dollari/ 2026-04-01T15:22:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-via-libera-ce-a-belumosudil-per-il-trattamento-della-malattia-cronica-da-trapianto-contro-lospite/ 2026-04-01T14:35:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-laderenza-terapeutica-come-leva-per-innovazione-e-sostenibilita-della-sanita-pubblica/ 2026-04-01T15:33:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jelena-ivanovic-aifa-eletta-co-chair-del-sottogruppo-per-lidentificazione-delle-tecnologie-sanitarie-emergenti-in-europa/ 2026-04-01T15:19:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-arriva-il-via-libera-fda-per-orforglipron-la-pillola-anti-obesita-a-giorni-il-lancio-con-il-brand-foundayo/ 2026-04-02T09:21:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-efpia-il-motore-economico-degli-studi-clinici-in-europa/ 2026-04-02T12:47:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-vertici-di-aifa-in-missione-istituzionale-in-giappone/ 2026-04-02T10:51:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-casa-bianca-pronta-a-colpire-le-aziende-che-non-investono-negli-usa-con-dazi-del-100/ 2026-04-02T13:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-acquisisce-la-divisione-cromatografia-di-jsr-per-accelerare-la-produzione-di-farmaci-biologici/ 2026-04-03T10:34:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipo-biotech-nel-primo-trimestre-2026-andamento-lento-ma-vendita-azioni-piu-remunerativa/ 2026-04-03T13:27:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-sigla-accordo-con-startup-usa-per-lo-sviluppo-di-nuove-terapie-anticorpali/ 2026-04-03T14:04:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotecnologie-accordo-triennale-italia-stati-uniti-biotecnopolo-di-siena-al-lavoro-su-linee-guida-e-progetti-strategici/ 2026-04-03T14:20:00+00:00 monthly 0.2